Back to Authors

Herbert, Andrew S.

0009-0001-5256-7733

A5052781458 | I2801122164

Mayo Clinic

United States Army Medical Research Institute of Infectious Diseases

Citations 1

A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): in silico and in vitro investigations

RSC Medicinal Chemistry | August 18, 2021 | Volume: 12 | Issue: 10 | Pages: 1757-1764

10.1039/d1md00202c | PMID 34778776

A novel hydroxyethylamine compound was synthesised that displayed biological potency against SARS-CoV-2.